These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8239318)

  • 1. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
    Antonini A; Leenders KL
    Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
    Antonini A; Leenders KL; Reist H; Thomann R; Beer HF; Locher J
    Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 receptor binding in dopa-responsive dystonia.
    Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
    Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
    Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
    Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
    Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride.
    Rinne JO; Laihinen A; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Oikonen V; Rinne UK
    J Neurol Sci; 1995 Oct; 132(2):156-61. PubMed ID: 8543941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride.
    Rinne JO; Hietala J; Ruotsalainen U; Säkö E; Laihinen A; Någren K; Lehikoinen P; Oikonen V; Syvälahti E
    J Cereb Blood Flow Metab; 1993 Mar; 13(2):310-4. PubMed ID: 8436624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine D2 receptors in patients with narcolepsy measured with PET and 11C-raclopride.
    Khan N; Antonini A; Parkes D; Dahlitz MJ; Meier-Ewert K; Weindl A; Leenders KL
    Neurology; 1994 Nov; 44(11):2102-4. PubMed ID: 7969966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
    Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
    Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
    Ito H; Okubo Y; Halldin C; Farde L
    Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
    Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors.
    Rinne JO; Hublin C; Partinen M; Ruottinen H; Ruotsalainen U; Någren K; Lehikoinen P; Laihinen A
    Neurology; 1995 Sep; 45(9):1735-8. PubMed ID: 7675236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
    Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
    Seeman P; Niznik HB; Guan HC
    Arch Gen Psychiatry; 1990 Dec; 47(12):1170-2. PubMed ID: 2244801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.